Ocular Therapeutix (OCUL) Ownership - Who owns Ocular Therapeutix?

Industry: @Pharmaceuticals Other

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

Pharmaceuticals Other

Address

15 Crosby Drive

Phone

+1 781 357-4000

Employees

267

Web

https://www.ocutx.com

Details

Group

Domestic Stock Funds

Fundamentals

OCUL

Capitalization

1.31B

P/E Ratio

N/A

Risk (Beta)

1.15

Dividend Yield

N/A

Total Cash

460M

Total Cash/Share

2.95

Total Debt

74.9M

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

0.50%

Revenue

61.1M

ROE

N/A

Book Value

378M

P/B Ratio

3.46

Cash Flow

N/A

Earnings

-1.08

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

16K

Current Ratio

16.64

Current Revenue Per Employee

61576.78

Dividends Per Share - Security

N/A

EBITDA

-119.81M

Float

N/A

Float - Current

N/A

Gross Income Margin

90.82

Revenue To Assets

-43.26

Shares Held By Institutions

1.03B

Shares Outstanding - Current

156M

Total Liabilities

139M

Total Volume MTD

N/A

Value

N/A

Gain YTD

89.238

View a ticker or compare two or three

Compare

OCUL

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For OCUL
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for OCUL (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a developer of therapies for diseases and conditions of the eye using its proprietary hydrogel platform technology

Industry Biotechnology